GLP‐1 analogue use in patients with sub‐optimally controlled type 1 diabetes or obesity improves weight and HbA1c

In conclusion, the addition of a GLP‐1 analogue to existing treatment resulted in significantly improved glycaemic control and weight loss in patients with type 1 diabetes. Copyright © 2016 John Wiley & Sons.

Source: Practical Diabetes - January 28, 2016 Category: Endocrinology Authors: Louise Curtis, Helen Holt, Tristan Richardson, Julia Knott, Helen Partridge Tags: Original article Source Type: research